Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Novozymes A/S
XMUN:NZM2
Novozymes A/S
XMUN:NZM2
Price:
60.58
EUR
2.61%
Market Closed
Market Cap:
€16.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently viewed
Price
Wall St Price Targets
NZM2 Price Forecast
Based on 20 analysts
Based on 20 analysts
+17% Upside
from
€60.58
today
Novozymes A/S (NZM2)’s 12-month stock price forecast through November 2027 has a consensus target of €70.61, implying 17% upside. The forecast is based on price targets from 20 Wall Street analysts.
NZM2 Analyst Rating
No ratings yet
No ratings yet
Novozymes A/S Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NZM2's stock price target?
Price Target
70.61
EUR
70.61
EUR
According to Wall Street analysts, the average 1-year price target for NZM2 is 70.61 EUR with a low forecast of 61.47 EUR and a high forecast of 80.76 EUR.
What is the Revenue forecast for Novozymes A/S?
Projected CAGR
7%
7%
Over the last 9 years, the compound annual growth rate for Revenue has been -13%. The projected CAGR for the next 8 years is 7%.
What is the Gross Profit forecast for Novozymes A/S?
Projected CAGR
7%
7%
Over the last 9 years, the compound annual growth rate for Gross Profit has been -13%. The projected CAGR for the next 8 years is 7%.
What is the Operating Income forecast for Novozymes A/S?
Projected CAGR
10%
10%
Over the last 9 years, the compound annual growth rate for Operating Income has been -15%. The projected CAGR for the next 8 years is 10%.
What is the Pre-Tax Income forecast for Novozymes A/S?
Projected CAGR
22%
22%
Over the last 9 years, the compound annual growth rate for Pre-Tax Income has been -17%. The projected CAGR for the next 3 years is 22%.
What is the Net Income forecast for Novozymes A/S?
Projected CAGR
14%
14%
Over the last 9 years, the compound annual growth rate for Net Income has been -17%. The projected CAGR for the next 8 years is 14%.
